2025 Diagnostics
Accelerator (DxA) Day
AD/PD registration required
DxA Day is an annual invite-only symposium that convenes and connects experts across the Alzheimer’s field who are focused on developing cutting-edge biomarkers and diagnostics that will transform how we detect and diagnose Alzheimer's and related dementias. Featuring scientists, academia, industry, and government professionals, this full-day event will include presentations, panel discussions, and a keynote session with many opportunities to engage and interact with the speakers and presenters. There will be ample time throughout the day for networking among attendees.
Discussions
Sessions
Invitation only
Speakers
Senior Director, Fluid Biomarker Program
Professor of Anatomy & Neurobiology, Neurology and Epidemiology at Boston University Schools of Medicine and Public Health, Senior Fellow at the Institute for Health Systems Innovation and Policy at the Questrom School of Business, and Director of Neuropsychology at the Framingham Heart Study
Co-Founder and Chief Science Officer, neotiv GmbH Research Group Leader, German Center for Neurodegenerative Diseases (DZNE)
CEO and Co-Founder of C2N Diagnostics
Joy Chambers-Grundy Professor of Brain Science at the School of Integrated Health Sciences at University of Nevada, Las Vegas (UNLV)
Co-Founder and Chief Science Officer at the Alzheimer’s Drug Discovery Foundation (ADDF)
VP, Head of Biomarkers at Biogen
Professor of Neurology, Lund University; Vice President, Eli Lilly
Professor and Klorfine Family Chair of Ophthalmology at University of Washington
Assistant Director, Diagnostics Accelerator
Founder, Chairman & CEO, Alamar Biosciences
Chief Technology Officer, Alamar Biosciences
Group Vice-President of Neuroscience Research and Clinical Development, Eli Lilly and Company; President, Avid Radiopharmaceuticals, Inc.
Executive Director of Drug Development at the Alzheimer’s Drug Discovery Foundation (ADDF)
CEO of the Alzheimer’s Drug Discovery Foundation (ADDF)
Executive Director and Head of Translational Medicine, Eisai Inc
Senior Director of Diagnostics Accelerator, Alzheimer’s Drug Discovery Foundation (ADDF)
Associate Director, Health and Life Sciences Team, Gates Venture
Professor of Neurochemistry and Chair of the Neurochemistry Lab at Amsterdam UMC
Associate Professor, Alzheimer Center Amsterdam
Product Development Manager at Fujirebio Europe NV
Product Development Manager at Fujirebio Europe NV
Chief Medical Officer, SVP Medical & Scientific Affairs, Beckman Coulter
Professor of Neurochemistry at the University of Gothenburg (Sweden) and University College London (UK), and a Clinical Chemist at Sahlgrenska University Hospital (Sweden)
Agenda At-A-Glance
Morning Session
Afternoon Session
Austria Center Vienna
Vienna, Austria
Bruno-Kreisky-Platz 1, 1220 Wien, Austria
This year's DxA Day will be held at the Austria Center Vienna.
Registration located on Level 0, outside of Hall F.